| Mitochondria and Iron: current questions | 2016/12/12 | English | 257 |
| D-dimer level in COVID-19 infection: a systematic review | 2020/10/12 | English | 210 |
| Relapse after allogeneic stem cell transplantation | 2010/08/01 | English | 131 |
| Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders | 2010/02/01 | English | 122 |
| Allogeneic hematopoietic cell transplantation: the state of the art | 2010/06/01 | English | 113 |
| Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field | 2012/01/01 | English | 112 |
| High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review | 2019/07/05 | English | 108 |
| An update on the biology and management of dyskeratosis congenita and related telomere biology disorders | 2019/09/10 | English | 104 |
| Akt signaling in platelets and thrombosis | 2010/02/01 | English | 102 |
| Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders | 2013/06/01 | English | 90 |
| Complications of thalassemia major and their treatment | 2011/06/01 | English | 88 |
| Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives | 2010/08/01 | English | 88 |
| Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis | 2013/02/01 | English | 87 |
| Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up | 2011/08/01 | English | 85 |
| Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health | 2011/04/01 | English | 84 |
| The bone marrow microenvironment and leukemia: biology and therapeutic targeting | 2011/06/01 | English | 82 |
| Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms | 2017/01/29 | English | 78 |
| Postpartum haemorrhage: prevention and treatment | 2016/10/20 | English | 77 |
| Immunoglobulin light chain amyloidosis | 2013/12/18 | English | 77 |
| Anemia in children: prevalence, causes, diagnostic work-up, and long-term consequences | 2017/10/12 | English | 76 |
| CXCL12 and CXCR4 in bone marrow physiology | 2010/06/01 | English | 76 |
| Why factor XI deficiency is a clinical concern | 2016/06/24 | English | 75 |
| Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities | 2010/06/01 | English | 72 |
| Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations | 2016/12/21 | English | 71 |
| Disseminated intravascular coagulation: an update on pathogenesis and diagnosis | 2018/07/20 | English | 69 |
| Classification and therapeutic approaches in autoimmune hemolytic anemia: an update | 2011/12/01 | English | 69 |
| Management of bone disease in multiple myeloma | 2014/01/16 | English | 67 |
| Hematological disorders: a commonly unrecognized cause of acute stroke | 2016/07/11 | English | 65 |
| Transfusion immunomodulation from a clinical perspective: an update | 2013/12/01 | English | 64 |
| An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura | 2019/05/20 | English | 63 |